earnings beatCINGfinnhub
Cingulate (CING) Beats Q2 Earnings Estimates by $0.13
Cingulate (NASDAQ:CING) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Cingulate (NASDAQ:CING) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreOvid Therapeutics (NASDAQ:OVID) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreOdysight ai (NASDAQ:ODYS) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreHeartCore Enterprises (NASDAQ:HTCR) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read morePDS Biotechnology (NASDAQ:PDSB) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreFate Therapeutics (NASDAQ:FATE) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreDogwood Therapeutics (NASDAQ:DWTX) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreNakamoto (NASDAQ:NAKA) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreAssembly Biosciences (NASDAQ:ASMB) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreEikon Therapeutics (NASDAQ:EIKN) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreMapLight Therapeutics (NASDAQ:MPLT) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreVivani Medical (NASDAQ:VANI) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreKodiak Sciences (NASDAQ:KOD) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreCaribou Biosciences (NASDAQ:CRBU) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreFathom Holdings (NASDAQ:FTHM) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read more4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
Read moreElicio Therapeutics (NASDAQ:ELTX) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreGossamer Bio (NASDAQ:GOSS) reported quarterly earnings results on August 13, 2026 that exceeded analyst expectations.
Read moreNGEX (NASDAQ:NGEX) is scheduled to report its Q2 earnings results on August 14, 2026 after market close.
Read moreNovo Nordisk A/S (NYSE:NVO) is scheduled to report its Q2 earnings results on August 14, 2026 after market close.
Read more